NVIDIA
the open developer platform for AI-driven life-science research packages structure prediction, molecular generation, docking, sequence analysis and genomics as callable BioNeMo Skills; its GenMol v2.0 (NV-GenMol-89M-v2) masked-diffusion model is commercial-ready,…
- Country
- United States
- Ticker
- NVDA
Commercial
Public (NASDAQ: NVDA)
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| bioinformatics-omics | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Biological AI & bioinformation services | bioinformatics-omics | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.